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1119-93 Any Measurable Coronary Artery Disease Identified in 
Women Presenting With Ischemic Chest Pain Is 
Associated With an Adverse Outcome: Findings From 
the National Institutes of Health-National Heart, Lung, 
and Blood Institute-Sponsored Womens Ischemia 
Syndrome Evaluation (WISE) Study Angiographic Core 
Laboratory
Barry L. Sharaf, Leslee Shaw, B. Delia Johnson, Sheryl F. Kelsey, Marian B. Olson, Sunil 
Mankad, William J. Rogers, Steven E. Reis, Carl J. Pepine, C. Noel Bairey Merz, Rhode 
Island Hospital, Providence, RI
Background: Minimal (Min) or non-obstructive coronary artery disease (CAD) is often
identified in women presenting with a suspicion of ischemic chest pain. Whether or not
this Min CAD is associated with an adverse outcome has not been well studied.
Methods: Accordingly, angiograms from 887 women undergoing clinically indicated cor-
onary angiography were analyzed by core laboratory for the presence of CAD. No CAD
(<20% stenosis), Min CAD (>20, <50%) and obstructive CAD (>50% stenosis) was iden-
tified in 37, 25, and 38% of women. A severity score (SS) was developed which assigned
points for any CAD (>20% stenosis) weighted by stenosis severity, location and collater-
als. A SS of 5 was assigned to those women with no CAD. Most (71%) women with Min
CAD had SS between 5.1 and 10. SS >50 represents severe, diffuse 3 vessel obstructive
CAD.
Results: The average age of the women presenting was 58yrs, with 25% diabetic.
Twenty percent were non-Caucasian. Death or MI at 3 yrs occurred in 1.9, 3.8 and 8.4%
of women with no, Min and obstructive CAD (p<0.0001). Death or MI rates by angio-
graphic severity score (figure) at 3 yrs of follow-up were 2.1, 6, 7.7, 9.3 and 12.4% for
those women with SS =5, 5.1-10, 10.1-20, 20.1-50 and >50 (p<0.0001).
Conclusions: CAD associated adverse outcome is identified even in those women with-
out obstructive lesions. Whether adverse outcome in these women with Min CAD is due
to endothelial or microvascular dysfunction or rupture of vulnerable, non-obstructive
plaque is unknown and deserves further study. 
1119-94 Reduced Functional Capacity in Women Is Associated 
With Impaired Vascular Function
Eileen Handberg, B. Delia Johnson, Christopher B. Arant, Timothy R. Wessel, Marian B. 
Olson, Steven E. Reis, Leslee Shaw, Sunil Mankad, William J. Rogers, C. Noel Bairey 
Merz, George Sopko, Carl J. Pepine, The WISE Investigators, University of Florida, 
Gainesville, FL, University of Pittsburgh, Pittsburgh, PA
Background: Reduced functional capacity is associated with poor prognosis, but the
basis for this link is not well understood in patients without heart failure. The Duke Activity
Status Index (DASI) is a validated assessment of functional capacity which has been cor-
related with outcome. Impaired vascular reactivity has also been associated with poor
prognosis. We examined the relationship of vascular reactivity and DASI scores in a
cohort of women enrolled in the NHLBI-WISE.
Methods: We examined DASI scores in 203 women with coronary flow reserve (CFR) to
adenosine assessments and 381 women with brachial artery flow mediated dilation
(FMD) assessments. DASI scores were converted to metabolic equivalents (MET).
Results: The mean age of all women was 57 + 11 (21-83), 14% were non-white, 40% had
a BMI > 30, and 32% had CAD (> 50% stenosis). Women with a CFR of <2.5 (n=97) had
a mean MET level of 4.8 + 4.1, compared to 6.5 + 4.9 in those women (n=106) with CFR
> 2.5 (p=0.009). Women with both CFR and FMD (n=83) are shown below, with p-value
(0.006) adjusted for age and presence of CAD.
Summary: Women with a CFR< 2.5 were significantly more likely to have a functional
impairment (a low DASI score), and women with both reduced CFR and FMD had the
lowest DASI scores (~ 3 METs). Impairment in vascular function may result in modifica-
tion of activity status and may help to explain poorer prognosis seen in women with
reduced functional capacity who are evaluated for suspected ischemia.
1119-95 N-Terminal-Pro Braintype Natriuretic Peptide Predicts 
Extent of Coronary Artery Disease and Myocardial 
Ischemia in Patients With Stable Angina Pectoris
Michael W. Weber, Roman Arnold, Torsten Dill, Matthias Rau, Vesselin Mitrovic, Klaus D 
Mueller, Christian Hamm, Kerckhoff Heart Center, Bad Nauheim, Germany
Background:. Recently its has been shown, that BNP and NT-proBNP are good predic-
tors for prognosis in acute coronary syndromes (STEMI and NSTEMI) and that NT-
proBNP increases after transient myocardial ischemia during coronary angioplasty.
Hypothesis: NT-proBNP is elevated in patients with stable angina pectoris and hemody-
namically relevant coronary artery disease (CAD) with exercise induced ischemia.
Methods: 94 patients (71 male, aged 62,3±8,7) with normal left ventricular function
referred for coronarangiography with suspected CAD were included. All patients under-
went exercise testing, coronarangiography and myocardial scintigraphy (n=91). Blood for
measurement of NT-proBNP was taken before and 15 minutes after maximal exercise.
Values are given as mean ± SEM.
Results: 58 patients had a hemodynamically relevant CAD (> 1 vessel with a stenosis >
70%) and in 52 patients ischemia was detected by myocardial scintigraphy. NT-proBNP
was elevated in patients with CAD (386±72 pg/ml vs. 148±29 pg/ml respectively ; p<0,01
Mann Whitney) and in patients with myocardial ischemia (396±80 pg/ml vs. 160±27 pg/
ml respectively; p=0,01; Mann Whitney). The increase in NT-proBNP correlated with the
number of stenosed vessels (3VD 624±186 pg/ml; 1/2VD 269±5 pg/ml; no CAD 148±29
pg/ml; p<0,01 Kruskal Wallis). There was no increase after maximal exercise in patients
with CAD (386±72 pg/ml respectively 393±74 pg/ml; n.s.). ROC curve analyses for NT-
proBNP as predictor for hemodynamically relevant CAD showed an AUC of 0,72
(p<0,01). Using an optimised cut-off level for NT-proBNP of 214 pg/ml we found a sensi-
tivity of 55%, a specificity of 78%, a NPV of 54%, a PPV of 84% and a total test efficiency
of 1,38. Adding NT-proBNP to exercise testing, CAD can be predicted with higher accu-
racy (sensitivity 83%, specificity 69%, NPV 71%, PPV 81% and total test efficiency 1,52)
Conlusions: NT-proBNP is elevated in patients with stable angina pectoris with a strong
correlation to the extend of coronary artery disease and myocardial ischemia. Combining
NT-proBNP with exercise testing the accuracy for predicting CAD can be improved.
Therefore NT-proBNP is of attributable value in the diagnostic process of stable angina
pectoris.
